e-learning
resources
Stockholm 2007
Tuesday 18.09.2007
Acute and chronic pulmonary embolism
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Fibrinogen AaThr312Ala polymorphism predisposes to chronic thromboembolic pulmonary hypertension
J. Suntharalingam, K. Goldsmith, V. van Marion, F. Dudbridge, M. Toshner, J. Pepke-Zaba, J. Eikenboom, N. Morrell (Papworth Everard, Cambridge, United Kingdom; Leiden, Netherlands)
Source:
Annual Congress 2007 - Acute and chronic pulmonary embolism
Session:
Acute and chronic pulmonary embolism
Session type:
Oral Presentation
Number:
2944
Disease area:
Pulmonary vascular diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
J. Suntharalingam, K. Goldsmith, V. van Marion, F. Dudbridge, M. Toshner, J. Pepke-Zaba, J. Eikenboom, N. Morrell (Papworth Everard, Cambridge, United Kingdom; Leiden, Netherlands). Fibrinogen AaThr312Ala polymorphism predisposes to chronic thromboembolic pulmonary hypertension. Eur Respir J 2007; 30: Suppl. 51, 2944
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
The definition of pulmonary hypertension: history, practical implications and current controversies
Comparison of acute phase reactant pentraksin-3 and inflammatory parameters in acute and stable pulmonary embolism
Features of patients newly diagnosed pulmonary embolism during COVID pneumonia
Related content which might interest you:
Chronic thromboembolic pulmonary hypertension
Source: Annual Congress 2007 - Update on venous thromboembolism
Year: 2007
ERS statement on chronic thromboembolic pulmonary hypertension
Source: ERS webinar 2021: ERS statement on chronic thromboembolic pulmonary hypertension
Year: 2021
Platelets and chronic thromboembolic pulmonary hypertension
Source: International Congress 2019 – Haemodynamics and chronic thromboembolic pulmonary hypertension
Year: 2019
Risk factors for chronic thromboembolic pulmonary hypertension
Source: Eur Respir Rev 2012; 21: 27-31
Year: 2012
Pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension: pathophysiology
Source: Eur Respir Rev 2009; 19: 59-63
Year: 2010
Chronic thromboembolic pulmonary hypertension
Source: International Congress 2017 – Russian Programme 2017
Year: 2017
Chronic thromboembolic pulmonary hypertension
Source: International Congress 2018 – State of the art session: Pulmonary vascular diseases
Year: 2018
Chronic thromboembolic pulmonary hypertension
Source: International Congress 2015 – ME5 Chronic thromboembolic pulmonary hypertension
Year: 2015
Chronic thromboembolic pulmonary hypertension
Source: Eur Respir J, 53 (1) 1801915; 10.1183/13993003.01915-2018
Year: 2019
Pulmonary function in patients with idiopathic pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension
Source: Annual Congress 2010 - Pulmonary circulation I
Year: 2010
Risk assessment in pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension
Source: Eur Respir J, 53 (6) 1802004; 10.1183/13993003.02004-2018
Year: 2019
Prevalence of chronic thromboembolic pulmonary hypertension (CTEPH) in patients after pulmonary embolism
Source: International Congress 2018 – Clinical aspects of pulmonary hypertension
Year: 2018
Evaluation of serum cytokines in patients with idiopathic pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension with hypercholesterolemia
Source: International Congress 2017 – PAH and CTEPH
Year: 2017
Angiogenesis in chronic thromboembolic pulmonary hypertension (CTEPH)
Source: Annual Congress 2012 - Pulmonary circulation: acute and chronic pulmonary embolism
Year: 2012
Fibrinogen Aα Thr312Ala polymorphism is associated with chronic thromboembolic pulmonary hypertension
Source: Eur Respir J 2008; 31: 736-741
Year: 2008
Involvement of the pulmonary micro-vasculature in chronic thromboembolic pulmonary hypertension (CTEPH)
Source: Annual Congress 2012 - Pulmonary circulation: clinical aspects of PAH, PTE and CTEPH
Year: 2012
Surgical and post-operative treatment of chronic thromboembolic pulmonary hypertension
Source: Eur Respir Rev 2009; 19: 64-67
Year: 2010
Prevalence of chronic thromboembolic pulmonary hypertension 2 years after pulmonary embolism
Source: Annual Congress 2008 - Pulmonary venous thromboembolic disease
Year: 2008
Chronic thromboembolic pulmonary hypertension (CTEPH) and beyond
Source: Annual Congress 2011 - Ceremony for Pulmonary Arterial Hypertension Award (supported by Actelion) followed by Pulmonary Hypertension in the Clinic Grand Round - an interactive session
Year: 2011
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept